Rapid developments in Regenerative Medicine and Tissue Engineering has witnessed an
increasing drive toward clinical translation of breakthrough technologies. However, the …

Cardiovascular disease is the leading cause of death worldwide, with this trend predicted to
continue for the foreseeable future. Common disorders are associated with the stenosis or …

Cardiovascular defects, injuries, and degenerative diseases often require surgical
intervention and the use of implantable replacement material and conduits. Traditional …

Occlusive arterial disease, including coronary heart disease (CHD) and peripheral arterial
disease (PAD), is the main cause of death, with an annual mortality incidence predicted to …

Developing advanced biocompatibility materials is of critical importance in biomedical
engineering. Polyhydroxyalkanoates (PHA), being famous for its flexible mechanical …

In the active field of vascular graft research, polycaprolactone is often used because of its
good mechanical strength and its biocompatibility. It is easily processed into micro and nano …

We developed a tissue-engineered vascular graft (TEVG) for use in children and present
results of a US Food and Drug Administration (FDA)–approved clinical trial evaluating this …

Pathologies related to the cardiovascular system are the leading causes of death worldwide.
One of the main treatments is conventional surgery with autologous transplants. Although …

Extensive and permanent damage to the vasculature leading to different pathogenesis calls
for developing innovative therapeutics, including drugs, medical devices, and cell therapies …

As the incidence of cardiovascular disease continues to climb worldwide, there is a
corresponding increase in demand for surgical interventions involving vascular grafts. The …